Paves the way for a stem cell bank of cord-blood derived iPSCs to advance regenerative medicine research
Investigators at Johns Hopkins report they have developed human induced-pluripotent stem cells (iPSCs) capable of repairing damaged retinal vascular tissue in mice. The stem cells, derived from human umbilical cord-blood and coaxed into an embryonic-like state, were grown without the conventional use of viruses, which can mutate genes and initiate cancers, according to the scientists. Their safer method of growing the cells has drawn increased support among scientists, they say, and paves the way for a stem cell bank of cord-blood derived iPSCs to advance regenerative medicine research.
In a report published Jan. 20 in the journal Circulation, stem cell biologist Elias Zambidis, M.D., Ph.D., and his colleagues describe laboratory experiments with these non-viral, human retinal iPSCs, created using the virus-free method Zambidis first reported in 2011.
“We began with stem cells taken from cord-blood, which have fewer acquired mutations and little, if any, epigenetic memory, which cells accumulate as time goes on,” says Zambidis, associate professor of oncology and pediatrics at the Johns Hopkins Institute for Cell Engineering and the Kimmel Cancer Center. The scientists converted these cells to a status last experienced when they were part of six-day-old embryos.
Instead of using viruses to deliver a gene package to the cells to turn on processes that convert the cells back to stem cell states, Zambidis and his team used plasmids, rings of DNA that replicate briefly inside cells and then degrade.
Next, the scientists identified high-quality, multipotent, vascular stem cells generated from these iPSC that can make a type of blood vessel-rich tissue necessary for repairing retinal and other human material. They identified these cells by looking for cell surface proteins called CD31 and CD146. Zambidis says that they were able to create twice as many well-functioning vascular stem cells as compared with iPSCs made with other methods, and, “more importantly these cells engrafted and integrated into functioning blood vessels in damaged mouse retina.”
Working with Gerard Lutty, Ph.D., and his team at Johns Hopkins’ Wilmer Eye Institute, Zambidis’ team injected the newly derived iPSCs into mice with damaged retinas, the light-sensitive part of the eyeball. Injections were given in the eye, the sinus cavity near the eye or into a tail vein. When the scientists took images of the mice retinas, they found that the iPSCs, regardless of injection location, engrafted and repaired blood vessel structures in the retina.
“The blood vessels enlarged like a balloon in each of the locations where the iPSCs engrafted,” says Zambidis. The scientists said their cord blood-derived iPSCs compared very well with the ability of human embryonic-derived iPSCs to repair retinal damage.
Zambidis says there are plans to conduct additional experiments of their cells in diabetic rats, whose conditions more closely resemble human vascular damage to the retina than the mouse model used for the current study, he says.
With mounting requests from other laboratories, Zambidis says he frequently shares his cord blood-derived iPSC with other scientists. “The popular belief that iPSCs therapies need to be specific to individual patients may not be the case,” says Zambidis. He points to recent success of partially matched bone marrow transplants in humans, shown to be equally as effective as fully matched transplants.
“Support is growing for building a large bank of iPSCs that scientists around the world can access,” says Zambidis, although large resources and intense quality- control would be needed for such a feat. However, Japanese scientists led by stem-cell pioneer Shinya Yamanaka are doing exactly that, he says, creating a bank of stem cells derived from cord-blood samples from Japanese blood banks.
The Latest on: Virus-Free Stem Cells
[google_news title=”” keyword=”Virus-Free Stem Cells” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Virus-Free Stem Cells
- Brain-Eating Amoeba Meets Its Match: Unusual Giant Virus Discovered in Austriaon April 26, 2024 at 5:25 am
A new, unusual giant virus has been discovered at a wastewater treatment plant near Vienna. The single-celled organism Naegleria fowleri ranks among the deadliest human parasites. Matthias Horn and Pa ...
- Therapeutic potential of human umbilical cord-derived mesenchymal stem cells in Crohn’s diseaseon April 25, 2024 at 6:00 am
Whether human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) could heal luminal ulcers in Crohn’s disease.
- Charles River (CRL) to Report Q1 Earnings: Here's What to Expecton April 24, 2024 at 9:47 am
Charles River Laboratories International, Inc. CRL is scheduled to report first-quarter 2024 results on May 9, before market open. Earnings Surprise History In the last reported quarter, the company’s ...
- FDA finds traces of bird flu virus in grocery store milk but says pasteurized dairy is still safeon April 24, 2024 at 5:37 am
Flu viruses enter cells through sialic acids, which serve as entry points. Right now, the H5N1 virus hasn’t learned to efficiently access the human version of the sialic acid receptor. Pigs have the ...
- 3D Cell Culture Market is expected to reach revenue of USD 5.0 Bn by 2032, at 12.0% CAGR: Insights by Dimension Market Researchon April 23, 2024 at 8:25 am
Exploring the Dynamics of the 3D Cell Culture Market by an In-Depth Analysis of Growth Trajectories, Key Players, and Future TrendsNew Jersey, New York, Los Angeles, Austin, San Diego, Philadelphia, ...
- Portuguese scientists create human stem cells to treat Machado-Joseph disease. What to knowon April 23, 2024 at 7:38 am
Portuguese scientists managed to create human stem cells from skin cells that have the potential for long-term treatment of Machado-Joseph disease.
- 40 years after discovery of HIV, another huge breakthrough is within our graspon April 23, 2024 at 5:38 am
Today marks 40 years since scientists discovered that HIV causes AIDs – and now, the UK could be just a few more years away from stopping transmission altogether. That is the hope of leading gay ...
- Researchers Develop a New Way to Safely Boost Immune Cells to Fight Canceron April 22, 2024 at 1:56 pm
New cancer immunotherapy developed to localize cancer-killing cytokines in tumors to improve treatment effectiveness ...
- Red flag warning sign in your throat could be a symptom of silent killeron April 20, 2024 at 1:53 am
In some cases, an early warning sign could also be a sore throat. But Healthline explains, this depends on “where the cancer starts”. Medical News Today adds that a sore throat and swollen lymph ...
- Will Conspiracy Theories Be Aaron Rodgers’s Achilles’ Heel?on April 19, 2024 at 12:00 am
The N.F.L. great was supposed to be the Jets’ savior. But since arriving in New York, he has spent more time voicing conspiracy theories than playing quarterback.
via Bing News